Posts in general
AllerGenis Announces Public Funding Campaign with StartEngine.com

December 29, 2022

CEO will present progress throughout 2022 and outlook for 2023. Allergenis, a commercial stage biotechnology company which aims to revolutionize the diagnosis and management of food allergy, today announced it is presenting at the upcoming Biotech Showcase™ 2023 conference, coinciding with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023.

read press release →

Read More
Allergenis to present at Biotech Showcase

December 29, 2022

CEO will present progress throughout 2022 and outlook for 2023. Allergenis, a commercial stage biotechnology company which aims to revolutionize the diagnosis and management of food allergy, today announced it is presenting at the upcoming Biotech Showcase™ 2023 conference, coinciding with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023.

read press release →

Read More